Population record
Saudi Arabia · 19 retained evidence mentions
Source-grounded findings
Supporting evidence
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| population | Saudi Arabia | “Delta SARS-CoV-2 triggered a devastating wave of COVID-19 in India, infecting approximately 26% of the population (~357 million people) within four months, with ~0.4 million new cases per day, and around 250,000 reported deaths. Phylogenomic analysis revealed that Pakistani isolates clustered primarily with Middle Eastern lineages, particularly from Saudi Arabia and Oman, suggesting international travel-linked introductions, rather than implying exclusive transmission routes.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Nepal's First Whole Genome Sequencing of the Monkeypox Virus: Imported Cases from Saudi Arabia with Evidences of Secondary Transmission. We present here 4 confirmed and probable cases managed at Sukraraj Tropical and Infectious Disease Hospital, Teku, Kathmandu. Three patients were Nepalese men returning from Saudi Arabia with fever, malaise, and papulopustular rashes.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Molecular Effect of Variants in Toll-like Receptor 4 Gene in Saudi Patients with Type 2 Diabetes Mellitus. Single-nucleotide polymorphisms (SNPs) in the Toll-like receptor 4 (TLR4) gene have been documented in type 2 diabetes mellitus (T2DM) and other diseases in the Saudi population. We investigated the relationship between rs11536889, rs4986790, and rs4986791 SNPs in the TLR4 gene and T2DM in the Saudi population; 105 patients with T2DM and 105 healthy controls were analyzed. The results suggest that rs11536889 and rs4986790 SNPs are genotypically and allelically associated with T2DM in Saudi patients.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “A scoping review on the impact of the COVID-19 pandemic on physical activity and sedentary behavior in Saudi Arabia. BACKGROUND: In Saudi Arabia, stay-at-home orders to address the coronavirus disease 2019 (COVID-19) pandemic between March 15 and 23, 2020 and eased on May 28, 2020. We conducted a scoping review to systematically describe physical activity and sedentary behavior in Saudi Arabia associated with the timing of the lockdown. Studies must have reported data from Saudi Arabia for any age and measured physical activity or sedentary behavior. Overall, 15 studies were cross-sectional, and 4 studies were prospective cohorts.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Knowledge and Practices of Child Eye Healthcare Among Parents in Aseer Region, Saudi Arabia. There are an estimated 1.4 million blind children worldwide, with roughly three-quarters of them living in developing countries. AIM: To evaluate parents' knowledge, attitudes, and practices related to pediatric eye medical services in Saudi Arabia's Aseer region.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Genetic Subtypes and Natural Resistance Mutations in HCV Genotype 4 Infected Saudi Arabian Patients. This study aimed to characterize the HCV genetic subtypes variability and the presence of natural occurring resistance-associated substitutions (RASs) in Saudi Arabia patients. GT 4a is the most common subtype in this small cohort of Saudi Arabia patients infected with hepatitis C infection.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “In the Kell system, the K-k+ phenotype was reported in 92.4 percent of individuals tested. MNS system phenotypes were comparable to the reports from Saudi Arabia and India, with M+N+S-s+ being the most prevalent (21.2%). MNS system phenotypes were comparable to the reports from Saudi Arabia and India, with M+N+S–s+ being the most prevalent (21.2%).” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “In this study, we consolidated HLA genotypes from 3.5-6.4 million individuals across up to 74 countries and modeled the country-specific cost-effectiveness of genetic testing. At incremental cost-effectiveness ratio thresholds of $40,000, testing of HLA-B*57:01 in patients initiating abacavir was cost-effective in the majority of countries with potential exceptions of East Asia, Saudi Arabia, Ghana, and Zimbabwe.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Unusual clinical features associated with congenital generalized lipodystrophy type 4 in a patient with a novel E211X CAVIN1 gene variant. Twenty seven cases of СGL type 4 from Japan, Oman, UK, Turkey, Mexico, Saudi Arabia, USA were reported previously.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients. In this prospective cohort study, the efficacy and safety of 8 weeks treatment duration with LDV/SOF was evaluated in HCV GT4 patients in Saudi Arabia.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “OBJECTIVES: To assess the outcome of a myringoplasty procedure during a 5-year period at a tertiary teaching hospital in Abha, Kingdom of Saudi Arabia. However, one patient of the 4 patients with failed graft stability demonstrated graft atrophy, and the remaining 3 developed graft infection.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Biopsies diagnosed as EB in the last 4 years were retrieved from the database of the king Khalid University Hospital and military hospital lab at Saudi Arabia. In 2 out of 4 cases of epidermolytic EB, cytokeratin 5/6 was seen only above the cleft, whereas 1 case revealed positivity above and below the blister.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Novel compound heterozygous mutations in MCPH1 gene causes primary microcephaly in Saudi family. METHODS: In present study we identified 4 generation Saudi family showing primary microcephaly. CONCLUSION: We found novel compound heterozygous mutation in Saudi family that will help to build database for genetic mutations in population and pave way to devise strategies to tackle such disorders in future.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Herein, we describe the clinical presentation of 4 patients from 2 unrelated Saudi families.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Sera samples collected from 20 male and 20 female treatment naïve CHC genotype 1 and 4 Saudi patients (ten males and ten females for each genotype), and 40 gender- and age-matched healthy participants were analysed for activin-A, activin-B and follistatin using enzyme-linked immunosorbent assay and their levels were correlated with IL-6, TNF-α, viral load and AST platelet ratio index (APRI).” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “For instance, genotype 4 is reported in hemodialysis patients in Iran. However it might be related to hemodialysis patients who travel to Saudi Arabia during Hajj as pilgrims, where they receive hemodialysis there. For participation in Haj meeting in Saudi Arabia and receiving dialysis during this period in that country.(5) Genotype 4 is very common in Saudi Arabia and the globalization and travel between countries can change the molecular epidemiology of HCV infection.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase type II deficiency in 4 Saudi children.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “At prevalence of 2.7% in the early 1990's, it is estimated that approximately 500,000 people in Saudi Arabia have been exposed to the hepatitis C virus (HCV). The incidence of newly acquired hepatitis C infection in Saudi Arabia has declined with the recent reported prevalence of approximately 1%. Hepatitis C genotype 4, the most predominant genotype in Saudi Arabia (62%) has been resistant to conventional interferon (IFN) therapy and sustained response rate to combination therapy with IFN plus ribavirin (RBV) has been poor. The recently completed Ministry of Health (MOH) clinical trial reports improved sustained virological response (SVR) rate of 65.2% among week 12 early responders of HCV genotype 4 chronic hepatitis patients using pegylated (PEG)-IFN alfa-2a (40 KD) plus RBV. With the aim of assessing these changes and defining a management strategy for HCV infected patients in Saudi Arabia, a consensus conference was held and consensus guidelines issued.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia | “OBJECTIVE: To assess the prevalence of human T-cell lymphotropic virus type I and type II antibodies in blood donors donating blood for various reasons in a University hospital and to compare the results with other reports from the Kingdom of Saudi Arabia (KSA), and elsewhere. Nine (0.04%) of the confirmed samples were from Saudi nationals. All 3 non-Saudi confirmed reactive donors were Indian nationals, while the 4 indeterminate cases, 2 were Saudis and 2 were Egyptians. The number of Saudi blood donors during this study was 16434 (80.3%) and non-Saudi donors was 4027 (19.7%). CONCLUSION: Based on these results it is shown that the prevalence of this virus is still low among blood donors in the Eastern region of Kingdom of Saudi Arabia.” | 0.95 | saudi_context_rules_v1 |